Clozapine is associated with an increased risk of Hodgkin and non-Hodgkin lymphoma
1Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract:
Clozapine is a cornerstone treatment for schizophrenia, though long-term use has been associated with significant adverse effects, including hematologic risks. This study analyzed FDA Adverse Event Reporting System (FAERS) data from 2003 to 2024 to assess the potential link between clozapine and lymphoma. Disproportionality analyses revealed elevated reporting odds ratios (RORs) for clozapine: Hodgkin lymphoma (HL) (3.76; 95% CI: 2.84-4.97) and non-Hodgkin lymphoma (NHL) (3.62; 95% CI: 2.88-4.54), while other antipsychotics showed no significant associations. Although causality cannot be established, the results underscore the need for targeted research into clozapine-associated risks and improved monitoring strategies to protect patients reliant on this medication. Further studies are essential to refine safety protocols and understand population-specific risks.
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
lncRNA - Long Non-coding RNAs
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Psychoneuroimmunology: Diabetes and Cancer
